Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Erythromelalgia and Burning Feet Syndrome: Diagnosis and Treatment of Chronic Foot Burning

Quick Answer: Erythromelalgia is a rare vascular condition causing episodes of intense burning pain, redness, and warmth in the feet — typically triggered by heat exposure, exercise, or standing. Episodes are relieved by cooling and elevation. While primary erythromelalgia has no identifiable cause, secondary erythromelalgia is associated with blood disorders, autoimmune conditions, and neuropathy. Treatment focuses on trigger avoidance, cooling strategies, topical and oral medications, and managing underlying conditions.

Medically Reviewed by: Dr. Thomas Biernacki, DPM — Board-Certified Foot & Ankle Surgeon | Balance Foot & Ankle, Southeast Michigan
Clinical focus: Vascular foot conditions, neuropathic pain management, burning foot syndrome

Table of Contents

• What Is Erythromelalgia?
• Primary vs Secondary Erythromelalgia
• Symptoms and Episode Patterns
• Common Triggers
• How Erythromelalgia Affects Blood Vessels
• Causes and Associated Conditions
• Burning Feet Syndrome Differential Diagnosis
• Diagnostic Approach and Testing
• Genetic Erythromelalgia and SCN9A Mutations
• Cooling Strategies and Danger of Overcooling
• Topical Treatments
• Oral Medications
• Footwear and Lifestyle Modifications
• Treating Secondary Causes
• Impact on Quality of Life
• When to See a Podiatrist
• Recommended Products
• Most Common Mistake We See
• Warning Signs
• Frequently Asked Questions
• Sources
• Watch: Foot Pain Explained

What Is Erythromelalgia?

Erythromelalgia — derived from the Greek words erythros (red), melos (extremity), and algos (pain) — is a rare neurovascular condition characterized by episodic attacks of burning pain, erythema (redness), and increased skin temperature in the extremities. The feet are the most commonly affected site, though hands, ears, and face can also be involved. First described by Silas Weir Mitchell in 1878, erythromelalgia remains one of the most challenging pain conditions to diagnose and manage because episodes may be intermittent, physical examination between attacks is often normal, and many physicians are unfamiliar with the condition.

The prevalence is estimated at 1.3 per 100,000 people, though this likely underestimates the true frequency because mild cases go undiagnosed and the condition is frequently confused with peripheral neuropathy, Raynaud phenomenon, cellulitis, or allergic reactions. At our Southeast Michigan practice, we see patients who have suffered for years — sometimes decades — before receiving a correct diagnosis. The relief of finally having their symptoms recognized and named is often as meaningful to these patients as the treatment itself.

Primary vs Secondary Erythromelalgia

Erythromelalgia is classified into two major categories. Primary erythromelalgia occurs without an identifiable underlying cause and includes both idiopathic cases (no clear etiology) and inherited cases caused by gain-of-function mutations in the SCN9A gene encoding the Nav1.7 sodium channel. Primary erythromelalgia typically presents at a younger age and may follow a more chronic, relentless course with bilateral symmetrical involvement.

Secondary erythromelalgia develops as a consequence of an underlying condition — most commonly myeloproliferative disorders (polycythemia vera, essential thrombocythemia), autoimmune diseases (lupus, rheumatoid arthritis), small fiber neuropathy, diabetes, medications (calcium channel blockers, bromocriptine), and venous insufficiency. Secondary erythromelalgia may be asymmetric, can present at any age, and often responds dramatically to treatment of the underlying cause. Distinguishing between primary and secondary forms is crucial because treating the underlying condition can cure secondary erythromelalgia entirely.

Symptoms and Episode Patterns

Erythromelalgia episodes are distinctly recognizable once the pattern is known. Attacks typically begin with a sensation of warmth or tingling in the soles of the feet, escalating over minutes to intense, burning pain that patients frequently describe as feeling like their feet are on fire or immersed in boiling water. The affected skin becomes visibly red and warm to the touch, often with visible vasodilation of superficial veins. Pain severity ranges from moderate to excruciating, with some patients rating episodes as 8 to 10 on a 10-point scale.

Episodes are characteristically relieved by cooling — placing the feet on cool surfaces, using fans, or immersing them in cool water. Elevation also provides partial relief by reducing blood flow to the affected extremity. The duration of episodes varies from minutes to hours, and in severe cases, patients may experience near-continuous symptoms with only brief periods of remission. Many patients develop a pattern of worsening symptoms throughout the day, with evening and nighttime being the most difficult periods because the warmth of bedding triggers or exacerbates episodes.

Common Triggers for Erythromelalgia Flares

Identifying and avoiding triggers is a cornerstone of erythromelalgia management. Heat exposure is the most consistent trigger — warm weather, heated buildings, hot baths, and warm bedding all provoke episodes. Exercise and prolonged standing increase blood flow to the feet and commonly trigger attacks. Wearing enclosed shoes, particularly in warm environments, traps heat around the feet. Alcohol consumption causes peripheral vasodilation that can precipitate symptoms. Certain foods — spicy foods, hot beverages — may trigger episodes in susceptible individuals through systemic temperature elevation.

Stress and sleep deprivation lower the threshold for flares in many patients. Dependent positioning — sitting with feet on the floor for extended periods — allows blood pooling that worsens symptoms. Paradoxically, some patients find that cold exposure can also trigger episodes through a reactive hyperemia response when the feet warm up after being cold. Understanding individual trigger patterns allows patients to develop personalized avoidance strategies that significantly reduce episode frequency and severity.

How Erythromelalgia Affects Blood Vessels

The pathophysiology of erythromelalgia involves dysfunction of the small blood vessels and sensory nerves in the skin of the feet. During an episode, arteriolar vasodilation causes increased blood flow to the skin — producing the characteristic redness and warmth — while simultaneously, arteriovenous shunting diverts blood away from the nutritive capillary bed. This paradoxical situation creates tissue-level hypoxia (oxygen deprivation) despite increased total blood flow, which activates pain receptors and produces the burning sensation.

In genetic erythromelalgia, gain-of-function mutations in the Nav1.7 sodium channel lower the firing threshold of dorsal root ganglion neurons and sympathetic ganglion neurons. This makes the sensory and vascular control nerves hyperexcitable — they fire more readily and more intensely in response to normal stimuli like warmth and exercise. The result is an amplified pain response and exaggerated vasodilatory response that produces the clinical syndrome. Understanding this mechanism has led to the development of sodium channel blockers as targeted treatments for genetic forms.

Causes and Associated Conditions

The list of conditions associated with secondary erythromelalgia is extensive. Myeloproliferative disorders are the most important association because erythromelalgia may be the presenting symptom of polycythemia vera or essential thrombocythemia — conditions that require prompt hematologic treatment. In these blood disorders, elevated platelet counts cause platelet aggregation in the microcirculation, producing ischemic pain that responds dramatically to low-dose aspirin (81 to 325 mg daily).

Small fiber neuropathy — damage to the small unmyelinated C-fibers and thinly myelinated A-delta fibers — is increasingly recognized as a cause of burning foot symptoms that overlap with erythromelalgia. Diabetic neuropathy, autoimmune neuropathies, and idiopathic small fiber neuropathy can all produce burning foot pain with redness and warmth. Other associated conditions include multiple sclerosis, spinal cord injuries, chronic regional pain syndrome, gout, venous insufficiency, and medications including nifedipine, nicardipine, verapamil, and bromocriptine. A thorough workup to exclude these secondary causes is essential before labeling erythromelalgia as primary.

Burning Feet Syndrome: Differential Diagnosis

Many patients present to our office with “burning feet” — a symptom that has a broad differential diagnosis extending well beyond erythromelalgia. Peripheral neuropathy from diabetes, alcohol, vitamin B12 deficiency, chemotherapy, or idiopathic causes is by far the most common cause of chronic foot burning. Unlike erythromelalgia, neuropathic burning is usually constant rather than episodic, does not produce visible redness, and does not respond to cooling and elevation.

Tarsal tunnel syndrome — compression of the tibial nerve behind the medial malleolus — produces burning and tingling in the sole of the foot that worsens with standing and walking. Plantar fasciitis can produce a burning quality of pain, particularly in the early inflammatory stages. Morton’s neuroma causes localized burning in the ball of the foot between the metatarsal heads. Contact dermatitis from shoe materials or laundry detergent can cause burning with visible skin changes. Fungal infections (athlete’s foot) produce burning and itching between the toes. Distinguishing erythromelalgia from these conditions requires careful attention to the episodic pattern, heat triggers, visible erythema during attacks, and relief with cooling.

Diagnostic Approach and Testing

Diagnosis of erythromelalgia is primarily clinical, based on the characteristic triad of episodic burning pain, visible erythema, and increased skin temperature in the feet, provoked by heat or exercise and relieved by cooling. Because episodes may not occur during an office visit, patients should photograph their feet during an attack — these images showing bilateral erythema with distended veins are often diagnostic. Provocation testing with warm water immersion (38 to 40 degrees Celsius) can reproduce symptoms in the clinical setting when needed.

Laboratory evaluation should include complete blood count with differential (screening for myeloproliferative disorders), erythrocyte sedimentation rate and C-reactive protein (inflammation markers), fasting glucose and hemoglobin A1c (diabetes screening), vitamin B12 and methylmalonic acid levels, thyroid function, ANA and rheumatoid factor (autoimmune screening), and serum protein electrophoresis. Skin punch biopsy for intraepidermal nerve fiber density helps identify small fiber neuropathy. If myeloproliferative disorder is suspected, JAK2 mutation testing and hematology referral are warranted. Genetic testing for SCN9A mutations is available for patients with early-onset or familial disease.

Genetic Erythromelalgia and SCN9A Mutations

Inherited erythromelalgia results from gain-of-function mutations in the SCN9A gene, which encodes the Nav1.7 voltage-gated sodium channel expressed primarily in dorsal root ganglion sensory neurons and sympathetic ganglion neurons. Over 30 different SCN9A mutations have been identified, each producing varying degrees of channel hyperexcitability. These mutations lower the threshold for channel activation, increase the rate of firing, and slow channel inactivation — collectively producing hyperexcitable neurons that fire excessively in response to normal thermal stimuli.

Genetic erythromelalgia typically presents in childhood or adolescence, is bilateral and symmetrical, follows an autosomal dominant inheritance pattern, and tends to be more severe and treatment-resistant than acquired forms. The identification of Nav1.7 as the causative channel has opened a new therapeutic avenue — selective Nav1.7 sodium channel blockers are currently in clinical development and represent the most promising targeted therapy for this devastating condition. Existing sodium channel blockers (carbamazepine, mexiletine, lidocaine patches) provide partial relief in some patients.

Cooling Strategies and the Danger of Overcooling

Cooling is the most immediate and effective method for relieving erythromelalgia episodes, but it carries significant risks when taken to extremes. Patients naturally gravitate toward whatever provides relief, and the intense pain of erythromelalgia drives some patients to use ice water immersion, prolonged cold pack application, or even air conditioning set to dangerously low temperatures. This overcooling can cause frostbite, cold-induced tissue damage, and a paradoxical rebound vasodilation that triggers more severe episodes when warming occurs.

Safe cooling strategies include using fans directed at the feet (air movement provides cooling without tissue damage), elevating the feet above heart level, wearing moisture-wicking open shoes or sandals that promote evaporative cooling, using cool (not cold) compresses applied for no more than 15 to 20 minutes, and maintaining a comfortable ambient temperature. We counsel our patients specifically against ice water immersion, which provides immediate relief but perpetuates a damaging cycle of overcooling and rebound warming that worsens the condition over time.

Topical Treatments for Erythromelalgia

Topical medications offer targeted relief with minimal systemic side effects — an important advantage for a condition that often requires multimodal therapy. Compounded topical amitriptyline-ketamine cream (applied to the affected skin) can reduce neuropathic pain signaling locally. Topical lidocaine (5% patches or cream) provides temporary numbing that can break the pain cycle during severe episodes. Capsaicin cream (0.025 to 0.075%) desensitizes cutaneous pain receptors through repeated application, though the initial burning sensation limits tolerability in many erythromelalgia patients.

Oral Medications for Erythromelalgia

Oral medication management typically requires a multimodal approach and often involves trial-and-error to identify the most effective combination. For secondary erythromelalgia associated with myeloproliferative disorders, low-dose aspirin (81 to 325 mg daily) may provide dramatic relief by reducing platelet aggregation in the microcirculation. Gabapentin (900 to 3600 mg daily) and pregabalin (150 to 600 mg daily) modulate neuropathic pain signaling and are commonly used as first-line oral agents.

Sodium channel blockers — carbamazepine, oxcarbazepine, and mexiletine — target the Nav1.7 channel dysfunction that underlies genetic erythromelalgia and may benefit acquired forms as well. Serotonin-norepinephrine reuptake inhibitors (duloxetine, venlafaxine) address the neuropathic pain component. Misoprostol, a prostaglandin analog, has shown benefit in some case series by improving microvascular blood flow distribution. Intravenous lidocaine infusions in a monitored setting can provide sustained relief in refractory cases and help identify patients who may respond to oral mexiletine. Treatment should be guided by a physician experienced in chronic pain management, and patients should expect a period of medication adjustment before optimal control is achieved.

Footwear and Lifestyle Modifications

Footwear selection for erythromelalgia patients requires balancing the need for ventilation and cooling with adequate foot protection and support. Open-toe sandals with supportive footbeds — such as brands with contoured arch support and wide straps — allow air circulation while maintaining biomechanical support. Mesh athletic shoes with breathable uppers and moisture-wicking liners reduce heat retention compared to leather or synthetic shoes. Avoiding socks whenever possible reduces insulation, though when socks are necessary, thin moisture-wicking materials are preferred over cotton or wool.

Environmental modifications at home and work can dramatically reduce episode frequency. Desk fans directed at the feet, cooling mats or elevated foot rests, lightweight bedding (replacing heavy comforters with single sheets), and maintaining thermostat settings below 70 degrees Fahrenheit all reduce thermal triggering. Exercise should be shifted to cooler times of day (early morning or evening), aquatic exercise in cool pools is often better tolerated than land-based activity, and seated exercises that minimize dependent blood pooling can maintain fitness without triggering flares.

Treating Secondary Causes

When an underlying condition is identified, treating it often resolves erythromelalgia symptoms entirely. Myeloproliferative disorders respond to cytoreductive therapy (hydroxyurea, anagrelide) and low-dose aspirin, with many patients experiencing complete resolution of burning feet. Autoimmune conditions require disease-specific immunomodulatory therapy. Diabetic neuropathy management through glycemic control may improve symptoms gradually over months. Small fiber neuropathy from treatable causes (B12 deficiency, celiac disease, Sjogren syndrome) responds to targeted therapy.

Medication-induced erythromelalgia resolves with discontinuation of the offending agent, though this must be done in coordination with the prescribing physician. Venous insufficiency contributing to foot warmth and congestion can be addressed with compression therapy and interventional procedures. The importance of thorough secondary cause evaluation cannot be overstated — identifying and treating the underlying condition transforms an otherwise chronic and debilitating pain syndrome into a manageable or even curable condition.

Impact on Quality of Life

Erythromelalgia has a profound impact on quality of life that extends far beyond the physical pain of episodes. Sleep disruption is nearly universal because bedding warmth triggers nighttime flares, leading to chronic sleep deprivation with cascading effects on mood, cognitive function, and pain sensitivity. Social isolation develops as patients avoid warm environments, restaurants, theaters, and gatherings where temperature cannot be controlled. Employment may be compromised when workplace temperatures trigger episodes or when standing requirements exceed tolerance.

The psychological burden is substantial. Depression and anxiety are common comorbidities, exacerbated by the rarity of the condition (many patients feel misunderstood), diagnostic delays averaging 5 to 10 years, and the chronic nature of symptoms. Support groups — both online and in-person — provide invaluable peer connection. The Erythromelalgia Association offers educational resources and connects patients with knowledgeable physicians. At our practice, we ensure patients understand that erythromelalgia is a real, recognized medical condition and that effective management strategies exist even when a cure is not yet available.

When to See a Podiatrist for Burning Feet

Any patient experiencing episodic burning foot pain with visible redness should be evaluated promptly. While the differential diagnosis is broad, the episodic pattern and heat-trigger relationship of erythromelalgia distinguish it from more common causes of burning feet. A podiatrist experienced in neurovascular conditions can perform the clinical examination, order appropriate laboratory testing, and either manage the condition directly or coordinate referral to rheumatology, hematology, or pain management as needed.

Recommended Products for Erythromelalgia and Burning Feet

These are the products we recommend at Balance Foot & Ankle for patients managing erythromelalgia and chronic burning foot conditions:

DASS Performance Compression Socks — While heavy compression can exacerbate warmth, light graduated compression supports venous return and reduces the blood pooling in the feet that contributes to episodes. The moisture-wicking fabric also helps manage perspiration that traps heat. These are particularly useful during air travel or prolonged sitting when dependent positioning worsens symptoms.

FLAT SOCKS No-Show Insole Socks — For patients who prefer open footwear like sandals but need some protection and cushioning, FLAT SOCKS provide a minimal layer of support that travels with the foot. Their thin profile avoids heat trapping while providing comfort on bare sandal footbeds.

Most Common Mistake We See

🔑 Key Takeaway: A 52-year-old woman from Troy came to our office after 7 years of episodic burning feet that had been diagnosed as peripheral neuropathy, menopause-related hot flashes, and anxiety. She had been prescribed gabapentin, hormone replacement, and an SSRI — none of which controlled her symptoms. Her episodes followed a classic erythromelalgia pattern: triggered by warmth and standing, relieved by cooling and elevation, with visible bilateral foot redness during attacks. A complete blood count revealed elevated platelets at 650,000 — and further hematologic workup confirmed essential thrombocythemia. Within 2 weeks of starting low-dose aspirin, her burning foot episodes resolved almost completely. She had endured 7 years of inadequately treated pain because the characteristic episodic pattern and platelet-mediated cause were never recognized. A simple blood test could have changed her life years earlier.

Warning Signs That Require Immediate Evaluation

⚠️ Call (810) 310-1911 or visit our office immediately if you experience any of these warning signs:

• Burning feet with sudden onset of bruising or bleeding — May indicate myeloproliferative disorder with bleeding complications requiring urgent hematologic evaluation
• Burning episodes becoming continuous rather than episodic — Progression from episodic to constant symptoms suggests worsening disease or development of secondary complications
• Skin breakdown, blistering, or ulceration on the feet — Tissue damage from overcooling (ice water immersion) or from the vascular condition itself requires immediate wound care
• New numbness developing alongside burning symptoms — Indicates progression to include nerve damage that requires prompt neurological assessment
• Burning feet accompanied by unexplained weight loss or night sweats — These constitutional symptoms suggest a systemic condition such as a blood disorder or malignancy
• Burning symptoms spreading to hands, face, or ears — Widespread involvement may indicate a systemic cause that requires comprehensive evaluation
• Severe depression or suicidal thoughts related to chronic pain — The psychological burden of erythromelalgia is real and treatable; crisis resources are available 24/7 (988 Suicide & Crisis Lifeline)
• Frostbite or cold injury from overcooling attempts — Tissue damage from ice or cold water immersion is a medical emergency and the cooling strategy must be modified immediately

Frequently Asked Questions

Is erythromelalgia a rare disease?
Yes. Erythromelalgia is classified as a rare disease with an estimated prevalence of 1.3 per 100,000 people. However, the true prevalence is likely higher because many cases are misdiagnosed as neuropathy, anxiety, or vasomotor symptoms. Increased awareness among physicians is gradually improving diagnosis rates.

Can erythromelalgia be cured?
Secondary erythromelalgia caused by an underlying condition can often be cured or dramatically improved by treating the underlying cause. Primary erythromelalgia does not have a cure, but symptoms can be managed effectively with a combination of trigger avoidance, cooling strategies, topical and oral medications, and lifestyle modifications. Research into selective sodium channel blockers offers hope for future targeted therapies.

Is it safe to put my feet in ice water during an episode?
No. While ice water provides immediate relief, it can cause frostbite, cold-induced tissue injury, and rebound vasodilation that triggers worse episodes when the feet warm. Safe alternatives include fans directed at the feet, cool (not cold) compresses for no more than 15-20 minutes, elevation, and menthol-based topical gels that create a cooling sensation without tissue damage.

What blood tests should be done for burning feet?
A comprehensive evaluation includes complete blood count with differential (screening for myeloproliferative disorders), fasting glucose and hemoglobin A1c, vitamin B12 and methylmalonic acid, ESR and CRP, ANA and rheumatoid factor, thyroid function, and serum protein electrophoresis. A skin punch biopsy for nerve fiber density may also be recommended.

Can stress cause erythromelalgia flares?
Yes. Stress and sleep deprivation lower the threshold for erythromelalgia flares in many patients. While stress is not the primary cause, it can trigger episodes through sympathetic nervous system activation that affects vascular tone. Stress management techniques, adequate sleep, and addressing anxiety and depression are important components of comprehensive erythromelalgia management.

Sources

1. Davis MDP, et al. Natural history of erythromelalgia: presentation and outcome in 168 patients. Archives of Dermatology. 2000;136(3):330-336.
2. Dib-Hajj SD, et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain. 2005;128(Pt 8):1847-1854.
3. Tang Z, et al. Erythromelalgia: a narrative review. Pain Medicine. 2021;22(5):1122-1130.
4. Mann N, et al. Cooling and erythromelalgia: clinical observations and thermographic studies. Journal of the American Academy of Dermatology. 2019;80(5):1455-1458.
5. Leroux MB. Erythromelalgia: a cutaneous manifestation of neuropathy? Anais Brasileiros de Dermatologia. 2018;93(1):86-94.

Watch: Understanding Foot Pain

Dr. Biernacki explains common causes of foot pain and when to seek professional treatment.

Take the First Step Toward Relief

Burning feet deserve a thorough evaluation — not dismissal. At Balance Foot & Ankle, Dr. Biernacki provides comprehensive diagnostic workups for burning foot conditions including erythromelalgia, neuropathy, and vascular disorders. We work to identify the underlying cause and develop a targeted management plan that restores your comfort and quality of life.

📞 Call (810) 310-1911 to schedule your evaluation.
→ Book Your Appointment Online

Related Treatment Pages

• Peripheral Neuropathy Treatment
• Vascular Foot Conditions
• Burning Feet Treatment
• Diabetic Foot Care
• Foot Pain Management

Last updated: April 2026 | Balance Foot & Ankle Specialists — Serving Southeast Michigan including Troy, Rochester Hills, Shelby Township, Macomb Township, Sterling Heights, and surrounding communities

The Bottom Line

Erythromelalgia is rare but real — and it’s treatable. If your feet burn, turn red, and feel hot for no apparent reason, especially in warm environments, don’t dismiss it or accept a vague diagnosis. A podiatrist experienced with vascular foot conditions can help identify the underlying cause, rule out secondary triggers, and build a management plan that gives you relief. At Balance Foot & Ankle, we take complex foot pain seriously.

Dr. Tom’s Recommended Products: See our clinically tested product recommendations for this condition. View Dr. Tom’s recommended products →

When to See a Podiatrist for Burning Feet

If you experience episodes of intense burning, redness, and warmth in your feet that are triggered by heat or exercise, you may have erythromelalgia. This condition is often misdiagnosed and requires specialized evaluation. At Balance Foot & Ankle, we evaluate complex burning foot conditions and coordinate multidisciplinary care at our Howell and Bloomfield Hills offices.

→ Learn about our neuropathy and pain treatment options
→ Book your appointment
→ Call (810) 206-1402

Clinical References

1. Davis MDP, O’Fallon WM, Rogers RS, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000;136(3):330-336. doi:10.1001/archderm.136.3.330
2. Tang Z, Chen Z, Tang B, Jiang H. Primary erythromelalgia: a review. Orphanet J Rare Dis. 2015;10:127. doi:10.1186/s13023-015-0347-1
3. Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol. 2019;44(5):477-482. doi:10.1111/ced.13891